Corcept Therapeutics (NQ: CORT )
28.75
USD
+0.61
(+2.17%)
Official Closing Price
Updated: 6:09 PM EST, Jan 19, 2021
Add to My Watchlist
Stories about Corcept Therapeutics
Stocks That Hit 52-Week Highs On Friday
January 15, 2021
From Benzinga
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
January 15, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
December 24, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
December 23, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
December 22, 2020
From Benzinga
The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data
December 18, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
December 17, 2020
From Benzinga
The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut
December 17, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
December 16, 2020
From Benzinga
The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal
December 16, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Monday
December 14, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
December 11, 2020
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street
December 11, 2020
From Benzinga
Corcept Therapeutics Sees Its Composite Rating Rise To 96
December 11, 2020
Stocks That Hit 52-Week Highs On Thursday
December 10, 2020
From Benzinga
The Daily Biotech Pulse: Roche & Moderna Strike COVID Testing Partnership, Rocket Pharma's Gene Therapy Readout, Breast Cancer Presentations
December 09, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
December 08, 2020
From Benzinga
Biggest Price Target Changes For Friday
November 27, 2020
From Benzinga
The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia
November 24, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
November 23, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
November 20, 2020
From Benzinga
The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger
November 20, 2020
From Benzinga
68 Biggest Movers From Yesterday
November 20, 2020
From Benzinga
Noteworthy Thursday Option Activity: CORT, CTRN, FBP
November 19, 2020
Tags
Stocks
From Market News Video
12 Healthcare Stocks Moving In Thursday's Intraday Session
November 19, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.